Ignite Creation Date:
2024-05-05 @ 11:28 PM
Last Modification Date:
2024-10-26 @ 10:34 AM
Study NCT ID:
NCT01337336
Status:
COMPLETED
Last Update Posted:
2017-05-30
First Post:
2011-04-15
Brief Title:
Chronic Obstructive Pulmonary Disease COPD-Related Outcomes and Costs for Patients on Combination Fluticasone Propionate-Salmeterol Xinafoate 25050mcg Versus Anticholinergics in a COPD-Comorbid DepressionAnxiety Population
Sponsor:
GlaxoSmithKline
Organization:
GlaxoSmithKline
Key Dates - Follows AllAPIJSON File Order
Start Date:
2010-10
Start Date Type:
None
Primary Completion Date:
2010-11
Primary Completion Date Type:
ACTUAL
Completion Date:
2011-03
Completion Date Type:
ACTUAL
First Submit Date:
2011-04-15
First Submit QC Date:
April 15 2011
Study First Post Date:
2011-04-18
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
2011-05-20
Results First Post Date Type:
ESTIMATED
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2017-05-25
Last Update Post Date:
2017-05-30
Last Update Post Date Type:
ACTUAL